S100P and hepatocellular carcinoma: In addition, as shown in Table 4, β-catenin-wild type HCCs with S100P expression had the highest frequencies of high tumor stage (75%) and ETR (57%), followed by HCC without S100P expression or the β-catenin mutation (62% and 40%, respectively).